INTRODUCTION
============

Acne vulgaris is a common skin disease that affects upwards of 85% of adolescents and frequently persists into adulthood. It is a disease of the pilosebaceous unit that is classically associated with hyperkeratinization, increased sebum production, and an inflammatory cytokine response thought to be triggered by the commensal bacterium *Propionibacterium acnes* (PA)[@B1][@B2]. Its pathogenesis is multifactorial and thought to involve complex and poorly understood lipid-associated pathways. Some observational studies show that abnormal sebum lipid composition is associated with worsened disease and that acne patients have low linoleate levels in skin while high levels prevent comedogenesis[@B3]. PA also metabolizes triglycerides into free fatty acids (FFAs) in the pilosebaceous unit and the density of PA is positively correlated with sebum secretion rate[@B4]. However, how lipids are directly involved in inflammatory responses seen in acne remains unclear.

G2A, also known as G protein-coupled receptor 132 (GPCR 132), is a stress-inducible GPCR and known receptor for oxidized lipids, with especially high affinity for the linoleic acid derivative 9-hydroxyoctadecadienoic acid (9-HODE). Linoleic acid is found in relatively high concentrations in sebum and is one of the FFAs known to undergo beta-oxidation in the pilosebaceous unit. In part due to its recent discovery, the immunologic roles of G2A still remain unclear. Models of atherosclerosis suggest an anti-inflammatory role as mice lacking G2A had greater accumulation of macrophages on the aortic wall, increased nuclear localization of nuclear factor-κB (NF-κB) p65 subunit, and increased IL-6 and monocyte chemoattractant protein-1[@B5]. In contrast, studies in keratinocytes suggest a more pro-inflammatory role[@B6].

Its role in skin disease and in response to microflora are emerging areas of interest. G2A was recently shown to mediate interactions between the host and gastrointestinal microflora. *Bacteroides* induced endogenous stimulation of G2A and is thought to quell immune responses; thus, G2A may also have a role in autoimmunity[@B7]. As G2A is also expressed in skin, it is hypothesized that this GPCR may also play a role in regulating the skin\'s immune response to environmental factors and the interaction between skin and its microflora[@B1][@B2][@B8].

Our study is the first to investigate the role of G2A in the context of a commensal skin bacterium. Studying G2A in the context of PA provides an opportunity for the understanding of acne pathogenesis and G2A as an immune regulator. First, while PA colonization, sebum production, and inflammatory cytokine induction are inextricably linked in acne[@B9][@B10][@B11], the consequences of lipid involvement and inflammation potentially cross-regulating pathways at a sight of colonization remains elusive. Second, understanding the role of G2A in response to PA will help define the immunomodulatory properties of this receptor in the context of bacteria and help delineate underlying mechanisms by which inflammatory responses to a commensal organism can be mediated[@B12]. Our study uses human monocytes to characterize these properties of G2A and also considers the potential clinical relevance of G2A in acne.

MATERIALS AND METHODS
=====================

Monocyte isolation
------------------

Human monocyte isolation followed protocol described by Schenk et al.[@B13]. Peripheral blood mononuclear cells (PBMCs) obtained from donors after consent approved by the UCLA Institutional Review Board in accordance with Declaration of Helsinki Principles. PBMCs isolated using Ficoll (GE Healthcare, Uppsala, Sweden) gradient centrifugation. Monocytes enriched with Percoll density gradient (GE Healthcare) and adherence in RPMI 1640 medium (Thermo Fisher Scientific) with 1% fetal calf serum (FCS; Omega Scientific, Tarzana, CA, USA) for 2 h. Adherent monocytes cultured in 10% FCS. Monocyte purity \>80% as measured by CD14 expression.

PA culture
----------

PA strain 6919 obtained from American Type Culture Collections (ATCC; Manassas, VA, USA) and grown on brucella agar with 5% sheep blood, hemin, and vitamin K (Thermo Fisher Scientific Remel Productions, Lenexa, KS, USA) at 37℃ for 3\~5 days in sealed chambers with Anaero Packs (Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan). Cultures grown under same conditions in reinforced clostridial medium (Oxoid, Basingstoke, England). Spectrophotometer OD~600~ used to determine bacterial log phase. Cultures diluted to final concentration of 0.5 multiplicity of infection (MOI) to stimulate cells.

Quantification of HODEs and hydroxyeicosatetraenoic acids by LC/MS/MS
---------------------------------------------------------------------

Supernatants from monocytes stimulated for 24 hours with 0.5 MOI PA were processed to measure concentrations of HODEs and hydroxyeicosatetraenoic acids (HETEs) using method adopted from Imaizumi et al.[@B14] LC/MS/MS performed using 4000 QTRAP (Applied Biosystems, Foster City, CA, USA) with electrospray ionization (ESI) source. High-performance liquid chromatography (HPLC) system used Agilent 1200 series LC pump with thermostatted autosampler (Agilent Technologies, Santa Clara, CA, USA). Chromatography performed using Luna C-18(2) column (3 µm particle, 150×3.0 mm). Data acquisitions and instrument control done with Analyst 1.4.2 software (Applied Biosystems). Detection accomplished with multiple reaction monitoring modes with negative ion detection. Collision energy, declustering potential, and collision cell exit potential optimized for each compound to obtain optimum sensitivity. Transitions monitored were mass-to-charge ratio (m/z): m/z 295.1→194.8 for 13-HODE; 295.0→171.0 for 9-HODE; 319.1→219.0 for 15-HETE; 319.1→115.0 for 5-HETE; 319→179 for 12-HETE.

Cytokine measurements by enzyme-linked immunosorbent assay
----------------------------------------------------------

IL-6, IL-8, and IL-1β levels in culture supernatants quantified by enzyme-linked immunosorbent assay (ELISA) using cytokine-specific capture antibodies and secondary biotin-conjugated antibodies (Thermo Fisher Scientific) in reference to recombinant proteins (eBioscience, San Diego, CA, USA) in 96-well plates (Corning, NY, USA). Plates blocked using phosphate-buffered saline (PBS) solution with 10% bovine serum albumin (BSA; Thermo Fisher Scientific, Waltham, MA, USA). Plates washed with PBS containing 0.005% Tween 20 (Sigma-Aldrich, St. Louis, MO, USA). Samples were assayed in triplicates.

RNA isolation, cDNA synthesis, and quantitative polymerase chain reaction
-------------------------------------------------------------------------

Total RNA isolated using Trizol reagent (Thermo Fisher Scientific) following manufacturer\'s recommendations and treated with RNase-free DNase. RNA isolated with Quick-RNA MiniPrep kit (Zymo Research, Irvine, CA, USA). RNA concentration and quality determined by spectrophotometry at OD~460~ and OD~480~. Samples reverse transcribed with iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA) at 25℃ 5 minutes, 42℃ 30 minutes, and 85℃ 5 minutes. Quantitative polymerase chain reaction (qPCR) performed using iQ SYBR Green Supermix (Bio-Rad) (40 cycles of 95℃ 5 minutes, 95℃ 10 seconds, 55℃ 20 seconds, and 72℃ 20 seconds). Glyceraldehyde-3-phosphate dehydrogenase amplification used as internal standard. Primers designed using Primer Express (Applied Biosystems). Gene expression level quantified by comparative method 2^−ΔΔCT^.

Flow cytometry
--------------

Cells for detection of G2A treated with 0.5 MOI PA, isotretinoin, and/or all-*trans*-retinoic acid (ATRA) incubated with anti-G2A polyclonal antibody (MBL International; Woburn, MA, USA), Immunoglobulin (Ig)G isotype control (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and secondary Alexa Fluor 488-conjugated antibody (Thermo Fisher Scientific). Between incubation steps, cells washed with PBS containing 1% bovine serum albumin. Cells fixed with 2% paraformaldehyde (Thermo Fisher Scientific), acquired on BD FACScan System, and analyzed using CellQuest-Pro software (BD, Franklin Lakes, NJ, USA).

Small interfering RNA transfection
----------------------------------

Small interfering RNA (siRNA) transfection performed with Lonza Nucleofector system with either the Lonza Human Monocyte Nucleofector kit or Lonza Cell Line Nucleofector kit V for human promyelocytic cell line THP-1 (Lonza, Basel, Switzerland). Scramble control and anti-G2A siRNA constructs were used at 1 µg per transfection (Thermo Fisher Scientific). Transfection efficiency of expression constructs assessed using the pmax-GFP construct (Lonza), and yielded average of 50% transfection rate.

Western blot analysis
---------------------

Detections of phospho-p44/42 mitogen-activated protein kinase (MAPK), phospho-p38 MAPK, and NF-κB p65 were performed using western blot. After PA treatment, cells lysed in buffer containing 1% Triton X-100 (Sigma-Aldrich) and Protease/Phosphotase Inhibitor Cocktail (Cell Signaling, Danvers, MA, USA). Protein concentrations assessed with Quick Start Bradford Protein Assay kit following manufacturer\'s protocol. Lysates loaded with Laemmli Sample Buffer onto Any kD Mini-PROTEAN-TGX pre-cast polyacrylamide gel (Bio-Rad) and separated by electrophoresis. Gels transferred onto polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA) and detected with primary antibodies for MAPK (Cell Signaling) or NF-κB (Sigma-Aldrich) pathways, secondary horse radish peroxidase-conjugated antibody (Abcam, Cambridge, England), and chemiluminescent substrate (Thermo Fisher Scientific) before visualization with ChemiDoc MP System (Bio-Rad).

Microarray of acne lesions
--------------------------

Total RNA from five acne lesions and five matched non-lesional controls was obtained from Diane Thiboutot (Pennsylvania State University, Hershey, PA, USA)[@B15]. Biopsies taken from backs of men and women without other skin diseases in biopsy areas. Gene expression profiles were re-measured using the Affymetrix GeneChip, Human Genome (HG)-U133A Plus 2.0 array platform to include *GPR132*, which was not included in the Trivedi et al. report[@B15]. Data analyzed as previously described[@B16]. Analysis identified 890 genes that were significantly elevated in acne lesions (fold-change≥1.5 and *p*\<0.05), compared to controls.

Other reagents
--------------

Neutralizing antibodies against Toll-like receptor 2 (TLR2) and TLR4, and control antibodies (BioLegend, San Diego, CA, USA); 9(S)-HODE (Cayman Chemical Company, Ann Arbor, MI, USA); human acute monocytic leukemia cell line THP-1 (ATCC) cultured in RPMI Medium 1640 supplemented with 10% FCS, 1% Sodium Pyruvate (Thermo Fisher Scientific), and Penicillin-Streptomycin-L-Glutamine (Corning); Tris/Glycine and Tris/Glyine/SDS buffers and blotting-grade blocker for western blot (Bio-Rad); all-*trans*-retinoic acid (retinoic acid) and isotretinoin (13-*cis*-retinoic acid \[13cRA\]) (Sigma-Aldrich) reconstituted in dimethyl sulfoxide (Thermo Fisher Scientific).

Statistical analysis
--------------------

Results expressed as means±standard error (SE) for the number of separate experiments indicated in each [Fig. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}. *Post hoc* two-tailed Student\'s t-test used for comparison between two groups. For [Fig. 4](#F4){ref-type="fig"}, [5B](#F5){ref-type="fig"}, to address increased likelihood of Type I errors when making comparisons over multiple groups, *p*-values adjusted using Bonferroni correction. For [Fig. 5A](#F5){ref-type="fig"}, *post hoc* two-tailed paired t-test performed to ensure analysis of paired samples. Significant differences considered for those with *p*-values ≤0.05.

RESULTS
=======

*GPR132* expression in monocytes upregulated by PA via TLR2
-----------------------------------------------------------

To test G2A expression under different conditions, we examined the effects of 9(S)-HODE and PA on THP-1 cells and primary human monocytes. G2A mRNA expression or the population of cells expressing G2A in either THP-1 or monocytes was unchanged after treatment with different concentrations of 9(S)-HODE ([Fig. 1A](#F1){ref-type="fig"}). In contrast, PA exposure increased the population of THP-1 cells expressing G2A approximately 35-fold compared to isotype control ([Fig. 1B](#F1){ref-type="fig"}), and increased the gene expression of *GPR132* in both THP-1 and monocytes by approximately 50% and 40%, respectively ([Fig. 1A](#F1){ref-type="fig"}, *p*\<0.05). We next assessed the effect of TLR2, an important mediator of innate immune system in response to PA[@B17]. We observed a significant 30% reduction in *GPR132* expression in monocytes pre-treated with TLR2 neutralizing antibody prior to addition of PA, as compared to the isotype control ([Fig. 1C](#F1){ref-type="fig"}, *p*\<0.01).

G2A ligand, 9-HODE, is upregulated by PA in human monocytes
-----------------------------------------------------------

9-HODE is a known ligand of G2A[@B1][@B2]. We sought to characterize the baseline levels of this ligand and related oxidized lipids produced from human monocytes as well as their inducibility with PA. Monocytes were treated with PA for 24 hours; then cell lysates were purified and analyzed with liquid chromatography and tandem mass spectrometry. We measured the oxidized forms of linoleic acid, 9-HODE and 13-HODE, as well as three oxidized forms of another FFA, arachidonic acid, 5-, 12-, and 15-HETE. Both 9-HODE and 13-HODE were found in significantly higher concentrations (5-fold and 10-fold, respectively) than all three HETEs. Exposing monocytes to PA increased the concentration of 9-HODE by approximately 2-fold ([Fig. 2](#F2){ref-type="fig"}, *p*\<0.001), whereas 13-HODE was not significantly altered. Of the three HETEs measured, only 15-HETE was found to be significantly upregulated by PA (*p*\<0.05); however, its concentration was notably less than the concentrations of both the HODEs.

*GPR132* knockdown monocytes exhibit increased inflammatory response
--------------------------------------------------------------------

To understand the immunomodulatory functions of G2A, we transfected THP-1 cells using siRNA oligonucleotides specific to G2A mRNA (siG2A), then measured gene expression and protein secretion of inflammatory cytokines IL-6, IL-8, and IL-1β, following exposure to PA. Our transfection methods consistently yielded approximately 50% knockdown of G2A mRNA expression when compared to the non-targeting oligonucleotide control (siCTRL) ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}, *p*\<0.05). Knockdown of the G2A gene in THP-1 cells led to an increase in inflammatory cytokines both in response to PA and G2A ligand 9(S)-HODE. A 24 hours incubation of siG2A transfected THP-1 cells with live PA resulted in increases of approximately 1.8-fold for IL-6 ([Fig. 3A](#F3){ref-type="fig"}, *p*\<0.01) and 1.3-fold for IL-8 ([Fig. 3C](#F3){ref-type="fig"}, *p*\<0.05), but no change in IL-1β; when compared to control ([Fig. 3E](#F3){ref-type="fig"}). At the mRNA level, G2A knockdown in THP-1 cells stimulated with PA resulted in approximately 2.2-fold increase of *IL6* ([Fig. 3B](#F3){ref-type="fig"}, *p*\<0.01), 3.9-fold increase of *IL8* ([Fig. 3D](#F3){ref-type="fig"}, *p*\<0.01), and 1.9-fold increase of *IL1B* ([Fig. 3F](#F3){ref-type="fig"}, *p*\<0.05) mRNA when compared to control. G2A knockdown THP-1 cells treated with 9(S)-HODE exhibited increases of approximately 2.7-fold for *IL6* ([Fig. 3B](#F3){ref-type="fig"}, *p*\<0.05), 1.2-fold increase for *IL8* ([Fig. 3D](#F3){ref-type="fig"}, *p*\<0.05), and 1.4-fold increase for *IL1B* ([Fig. 3F](#F3){ref-type="fig"}, *p*\<0.001) when compared to control. At the protein level, there was nearly a 2.3-fold increase of IL-8 ([Fig. 3C](#F3){ref-type="fig"}, *p*\<0.05) when comparing PA-stimulated cells transfected with siG2A to siCTRL, while levels of IL-6 and IL-1β were not significantly changed.

Knockdown of GPR132 in monocytes results in an increase in the activation of ERK1/2 and NF-κB p65 pathway
---------------------------------------------------------------------------------------------------------

The MAPK and NF-κB pathways are thought to be integral in the regulation of inflammatory cytokines IL-6 and IL-8. To elucidate the signaling pathways that are activated by G2A to regulate inflammatory response, we measured the phosphorylation of two MAPK pathways, ERK1/2 (p44/42) and p38 MAPK, and NF-κB p65 using western blot. Densitometric analysis of blot bands showed that the G2A knockdown in monocytes stimulated with PA exhibited approximately 2.3-fold increase in the phosphorylation of the ERK1/2 MAPK pathway compared to control ([Fig. 4A](#F4){ref-type="fig"}, *p*\<0.01), and nearly a 1.5-fold increase in NF-κB p65 subunit ([Fig. 4C](#F4){ref-type="fig"}, *p*\<0.05). PA induced approximately a 50% increase in the phosphorylation of p38 MAPK in the scramble control group ([Fig. 4B](#F4){ref-type="fig"}, *p*\<0.05); however, this was not found to be significantly modulated by the G2A knockdown.

*GPR132* is upregulated in acne lesions
---------------------------------------

To explore the potential clinical implications of G2A in acne, we compared the mRNA profile of acne lesions to normal skin. Total RNA samples from punch biopsies of five acne lesions and matched non-lesional controls (normal skin) were obtained from D. Thiboutot[@B15]. mRNA expression profiles were assessed using Affymetrix gene expression microarray system. For each of the donors, G2A mRNA expression (*GPR132*) was higher in the acne lesion biopsies than in the matched controls. When the expression values of donors were averaged, the mean *GPR132* expression was doubled ([Fig. 5A](#F5){ref-type="fig"}, *p*\<0.001) in acne lesions compared to normal skin. Comparison of secretoglobin *SCGB1D2* (*p*\<0.01) and human beta-defensin 4 DEFB4 (*p*\<0.05) from the current data set corroborates previously published microarray data obtained from the same lesional and control samples using a previous version of the Affymetrix human array (U133A 2.0)[@B15].

PA and isotretinoin, but not all-*trans*-retinoic acid, upregulate G2A in human monocytes
-----------------------------------------------------------------------------------------

Retinoids, a class of vitamin A-derived compounds that bind various members of the retinoic acid receptor[@B18][@B19][@B20], affect keratinocyte maturation and anti-inflammatory activity[@B21][@B22]. Retinoids also downregulate TLR2 expression in monocytes[@B23]. We investigated whether 13cRA and ATRA, two widely used therapeutics for acne[@B24][@B25] could regulate G2A expression in monocytes. Monocytes were pre-treated with 13cRA and ATRA for 1 hour prior to a 24 hours exposure to live PA. These monocytes were then labeled with anti-G2A antibodies and analyzed using flow cytometry. Compared to control, ATRA alone did not induce a significant change in the percentage of cells expressing G2A but 13cRA induced a 10-fold increase ([Fig. 5B](#F5){ref-type="fig"}, *p*\<0.001). When exposed to PA, monocytes exhibited a 100-fold increase in the percentage of cells expressing G2A compared to untreated cells (*p*\<0.0001). Concurrent treatment with ATRA did not significantly modulate the PA-induced upregulation of G2A whereas 13cRA increased G2A expression on monocytes by approximately 30% compared to PA alone (*p*\<0.05).

DISCUSSION
==========

The active disease site of acne is the pilosebaceous unit, a lipid-rich environment where the commensal microbe PA colonizes and can induce inflammation. While increased sebum production is observed in acne, the mechanism by which lipids play a role in pathogenesis remains unclear. G2A provides one model that illustrates how lipid receptors may attenuate inflammation to a bacterium and regulate immune response to normal skin microflora.

We studied G2A in response to PA in human monocytes given previous studies showing relatively high levels of G2A monocyte expression and that monocytes are consistently used to study inflammatory responses to PA[@B5][@B17][@B26][@B27]. First, we found that both G2A is inducible by PA and may potentiate an anti-inflammatory cascade, as we see through our G2A knockdown model leading to upregulation of pro-inflammatory cytokines: IL-6, IL-8, and IL-1β, markers associated with PA-induced inflammation[@B28]. These cytokines play pivotal roles in host defense[@B29], neutrophil signaling, lysosomal pathways[@B30], and early innate immune responses to bacterial pathogens[@B31].

G2A has high affinity for the stable oxidized linoleic acid derivative, 9-HODE[@B17]. We show that the G2A ligand, 9-HODE, is also found in higher concentrations from monocytes in response to PA, presumably through an oxidative process, thus introducing a possible pathway by which oxidative changes to FFAs modulate downstream inflammatory responses. The inflammatory properties of 9-HODE has not been characterized in skin. However, there are studies from the atherosclerosis model that show that these lipids play a role in regulating monocyte function, such as retaining monocytes at the sites of inflammation[@B32][@B33]. We acknowledge, however, that our findings can only suggest a possible autocrine or paracrine response among monocytes and does not completely model the interaction between G2A and 9-HODE from sebum and resident skin cells.

In response to PA exposure, G2A response appears connected to innate immune pathways as its effects are partially mediated by TLR2, which is sufficient for the activation of NF-κB in response to PA exposure required for the later downstream pro-inflammatory cytokine promoter activity[@B17]. We observed a significant 30% reduction in G2A expression in monocytes treated with TLR2 neutralizing antibody as compared to cells pretreated with IgG isotype control. Furthermore, TLR downstream signaling pathways ERK1/2 MAPK and NF-κB p65, but not the p38 pathway, was reduced following PA simulation in G2A-knockdown monocytes. This discrepancy of MAP kinase pathway activation is also seen in other models[@B34], such as in osteoblasts and corneal epithelial[@B35]. One possible explanation for this bifurcation may be due to the known differences of p44/42 versus p38 MAP kinase pathways---e.g., the p44/42 isoforms of MAP kinase are more associated with growth factors and GPCRs. The question of whether there is crosstalk between G2A, a GPCR, and TLR2; or whether these two receptors modulate activation of NF-κB and MAP kinase independent of one another remains to be elucidated. However, there is a growing body of knowledge that shows how GPCRs and TLRs can exhibit reciprocal activity by regulating the signaling of each other[@B36].

By looking at the effects of retinoic acids on G2A and analyzing RNA samples from acne lesions, we sought to associate G2A to the clinical setting. One of the desired outcomes of isotretinoin treatment is a reduction of inflammation by a mechanism incompletely understood[@B37][@B38]. Given that isotretinoin induced higher expression of G2A in monocytes, and attenuated pro-inflammatory cytokines IL-6 and IL-8, this mechanism may suggest that this reduction in inflammation clinically may be associated with its effect on G2A[@B36][@B39][@B40][@B41][@B42]. Our findings that G2A is upregulated in monocytes in response to PA was mirrored in acne lesion punch biopsies compared to matched normal skin. While acne lesions are characterized by increased inflammation, it is known that there are concurrent anti-inflammatory and anti-microbial pathways that are activated during disease, such as through antimicrobial peptides and IL-10[@B43][@B44]. While our skin biopsies contain a milieu of both resident skin cells and immune cells, the general upregulation of G2A in the skin as well as in monocytes may act as one of these anti-inflammatory pathways.

Our main goals in studying G2A were to define a possible mechanism by which lipids mediate inflammation in response to the PA and to further elucidate the immune regulatory roles of this receptor, especially in light of recent findings that G2A may be important in regulating immunity to commensal bacteria. Yet an important question that remains is whether G2A expression correlates with acne severity. As Cohen et al.[@B7] showed that G2A may play a role in controlling immune response to gut commensal bacteria, we can speculate that patients with severe acne may either have dysregulated expression of G2A in response to PA colonization or that the effects of G2A in acne patients may be an appropriate response to commensal bacterium in the context of acne disease driven by other inflammatory pathways. Furthermore, while we were able to demonstrate a global upregulation of G2A expression in acne lesions, because of the inherent difficultly of obtaining acne lesion biopsies, our study was limited in its ability to relate G2A clinically. Rather, the scope of this study focused on the molecular mechanisms by which G2A may mediate innate immune response to PA and introduce a mechanism by which lipids may mediate inflammatory in acne pathogenesis.

In summary, we show that G2A is upregulated in acne lesions, and both G2A and its ligand are upregulated by PA and may play an important anti-inflammatory function that quells pathogenesis to a commensal bacterium. Here we also introduce a possible pathway by which acne pathogenesis is regulated by lipid mediators and help further understand the immune functions of G2A.
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SUPPLEMENTARY MATERIALS
=======================

Supplementary data can be found via <http://anndermatol.org/src/sm/ad-29-688-s001.pdf>.

###### Supplementary Fig. 1

Efficiency of *GPR132* knockdown using small interfering RNA (siRNA). Transfection of THP-1 cells using siRNA and electroporation consistently yielded at least a 50% knockdown of *GPR132* mRNA expression measured by quantitative polymerase chain reaction when compared to the control siRNA.

###### Supplementary Table 1

Quantitative polymerase chain reaction primer sequences

![*Propionibacterium acnes* (PA), but not 9-hydroxyoctadecadienoic acid (9-HODE), upregulates G2A in monocytes via a Toll-like receptor 2 (TLR2)-dependent mechanism. (A) Quantitative polymerase chain reaction (qPCR) and (B) fluorescence-activated cell sorting (FACS) analysis revealed that PA, but not 9-HODE, upregulates both the mRNA expression and the population of cells expressing G2A in both the THP-1 cell line and in primary human monocytes. Values from PCR are shown as mean±standard error (SE) (n=4) and FACS data is representative of three independent experiments. (C) Blocking antibody to TLR2 neutralized the upregulation of G2A mRNA expression by PA in monocytes. Values are expressed as mean±standard error (n=3). MOI: multiplicity of infection, IgG: immunoglobulin G. ^\*^*p*\<0.05, ^\*\*^*p*\<0.01.](ad-29-688-g001){#F1}

![Induction of 9-hydroxyoctadecadienoic acid (9-HODE) in human monocytes by *Propionibacterium acnes* (PA). Mass spectrometry analysis of G2A ligand and linoleic acid derivative, 9-HODE, and arachidonic acid derivative, 15-hydroxyeicosatetraenoic acids, in human monocytes by PA. Values are expressed as mean±standard error and were compiled from three independent experiments. MOI: multiplicity of infection. ^\*^*p*\<0.05, ^\*\*^*p*\<0.001.](ad-29-688-g002){#F2}

![Effects of G2A knockdown on interleukin (IL)-6, IL-8, and IL-1β cytokine secretion and gene expression. The secreted protein and mRNA from G2A knockdown THP-1 cells were analyzed using enzyme-linked immunosorbent and quantitative polymerase chain reaction. (A) G2A knockdown enhanced IL-6 secretion in response to *Propionibacterium acnes* (PA) and (B) upregulation of *IL6* gene expression in response to PA and 9-hydroxyoctadecadienoic acid (9-HODE). (C) G2A knockdown enhanced IL-8 response to PA and 9-HODE both at the protein level and the gene (D) level. (E) G2A knockdown had no measureable effect on IL-1β cytokine response to PA or 9-HODE, (F) but enhanced IL-1β response to PA and 9-HODE at the gene level. Values are expressed as mean±standard error (n=4). siRNA: small interfering RNA. ^\*^*p*\<0.05, ^\*\*^*p*\<0.01, ^\*\*\*^*p*\<0.001.](ad-29-688-g003){#F3}

![Effects of G2A knockdown on ERK1/2 and nuclear factor kappa B (NF-κB) p65 activation. (A\~C) Western blot studies on human monocytes using an anti-G2A small interfering RNA (siRNA). G2A was partially knocked down in human monocytes using an anti-G2A siRNA. These cells were then analyzed using western blot to measure differences in activation of select molecular pathways in response to *Propionibacterium acnes* (PA). ^\*^*p*\<0.05.](ad-29-688-g004){#F4}

![G2A mRNA expression in acne lesions and human monocytes. (A) Assessment of RNA isolated from acne lesions and matched normal skin revealed an increase in the gene expression for G2A, *GPR132*. Also shown are the negative and positive controls, *SCGB1D2* and *DEFB4*, respectively. Values connected by points are from individual donors and values expressed by a bar are mean values (n=5). (B) G2A expression in human monocytes in response to *Propionibacterium acnes*, all-*trans*-retinoic acid (ATRA), and 13-*cis*-retinoic acid (13cRA) as measured by fluorescence-activated cell sorting analysis. Values are expressed as percentage of cells expressing G2A (n=3). ^\*^*p*\<0.05, ^\*\*^*p*\<0.01, ^\*\*\*^*p*\<0.001.](ad-29-688-g005){#F5}
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